Showing 321-330 of 1407 results for "".
Initial Visits and Long-term Care of Glaucoma Patients in Primary Eye Care Settings
https://modernod.com/topics/glaucoma/initial-visits-and-long-term-care-of-glaucoma-patients-in-primary-eye-care-settings-1/36866/Which technologies are essential to conducting a thorough examination for new glaucoma patients? And which modalities and softwares are most useful for long-term care? Danica Marrelli, OD, and Anu Laul, OD, compare their approaches to initial encounters with glaucoma patients, swap notes on their prCOLLAB CORNER - Recognizing the Red Flags of Keratoconus
https://modernod.com/podcasts/collaborative-corner-the-podcast/recognizing-the-red-flags-of-keratoconus/36876/Marc R. Bloomenstein, OD, FAAO, invites John Gelles, OD, FAAO, FIAO, FCLSA, to review risk factors and red flags that all optometrists should know for detecting the early signs of keratoconus. Dr. Gelles shares insights from a study on pediatric keratoconus and highlights the importance of screeningEducating Patients About Refractive Solutions
https://modernod.com/podcasts/the-mod-pod/educating-patients-about-refractive-solutions/39862/In this episode, Marc R. Bloomenstein, OD, FAAO, invites Nicholas Bruns, OD, FAAO, to share advice for how to talk to patients about the pros and cons of different refractive procedures like LASIK, photorefractive keratectomy (PRK), and EVO ICL (Staar Surgical) implantation. Dr. Bruns reviews the poGut Health Linked with Dry Eye Disease
https://modernod.com/videos/eye-care-insiders/gut-health-linked-with-dry-eye-disease/39854/The gut microbiome plays a key role in systemic health, and dysregulation of the gut microbiota can lead to any number of complications, including dry eye. In this episode, Joseph J. Allen, OD, FAAO, Dipl ABO, discusses the current literature linking dry eye with gut dysbiosis and what ODs can do toCOLLAB CORNER - Integrating New Technology Into Practice
https://modernod.com/podcasts/collaborative-corner-the-podcast/collab-corner-integrating-new-technology-into-practice/39857/Marc R. Bloomenstein, OD, FAAO, invites Ryan Corte, OD, to the podcast to share his experience launching his podcast, building his personal and practice brands, and facilitating the education and mentorship of younger optometrists. Dr. Corte shares advice for how young optometrists can gain advantagOSD’s Greatest Hits: 2024 Edition
https://modernod.com/podcasts/to-the-point/osds-greatest-hits-2024-edition/36942/In this month’s episode of To the Point, Jackie Garlich, OD, FAAO, and Cecelia Koetting, OD, FAAO, Dipl ABO, talk about the most exciting, important, and novel ocular surface disease (OSD) news to come out of the past year, including FDA approvals, product launches, new clinical data, and more. TheyTreating CCH With RF
https://modernod.com/podcasts/to-the-point/treating-cch-with-rf/36938/Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, discuss the benefits of using radio frequency to treat conjunctivochalasis (CCH) with Edward H. Jaccoma, MD, an ophthalmologist who specializes in dry eye and ocular aesthetics. Dr. Jaccoma also offers his insights for patient educatio82. Mastering Refraction
https://modernod.com/podcasts/four-eyes/82-mastering-refraction/37032/In this episode, Drs. Kar and Bilkhu share their personal tips to help new grad ODs master refraction skills. Learn from their experiences to reduce pesky prescription redos, create an exceptional patient experience, and even boost optical sales as an associate OD. These insights will help you buildPreoperative Considerations for the Ocular Surface
https://modernod.com/podcasts/to-the-point/peroperative-considerations-for-the-ocular-surface/36937/Nandini Venkateswaran, MD, joins Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, this month on To the Point to share her insights on preoperative ocular surface considerations. Dr. Venkateswaran offers her approach to optimizing the ocular surface, educating patients on the importanTreating OSD in 2024
https://modernod.com/podcasts/to-the-point/treating-osd-in-2024/36930/Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, kick off 2024 with a conversation about several new and anticipated products for treating ocular surface disease, including cyclosporine ophthalmic solution 0.1% (Vevye, Harrow), perfluorohexyloctane ophthalmic solution (Meibo, Bausch